Insight

On November 5, PDA published the revised 2025 edition of Technical Report No. 26 (TR26): Sterilizing Filtrationof Liquids, superseding the 2008 version. This revision incorporates extensive updates covering filter selection, validation, operation, integrity testing, and sterilization. It establishes scientific methodologies for selecting and validating filters used in liquid sterilizing filtration, aligning with current industry best practices and global regulatory expectations.

Full Document Interpretation

The technical report establishes a comprehensive technical framework spanning the entire lifecycle of sterilizing filters, including selection, validation, operational deployment, integrity testing and sterilization workflows. Its scope has been expanded to cover conventional pharmaceutical manufacturing, biological products, and emerging modalities such as Advanced Therapy Medicinal Products (ATMPs).

Clarification of Key Terminology with Venn Diagram Illustrations

The report resolves widespread terminology confusion by delineating three core filter classifications, supplemented by Venn diagrams to demonstrate their logical relationships

0.2 μm or 0.22 μm Rated Filter

These filters bear a nominal pore size rating of 0.2 μm or 0.22 μm, and may or may not have passed the ASTM F838 bacterial retention test. The “rated” designation refers solely to nominal pore dimension and does not inherently confirm sterilization capability. Certain 0.22 μm-rated filters are deployed exclusively for bioburden reduction without sterilization validation. A filter cannot be classified as a sterilizing-grade filter merely based on its 0.22 μm nominal pore rating.

Sterilizing-Grade Filter

Manufacturers validate these filters against standardized ASTM F838 testing to demonstrate complete retention of a minimum challenge load of 10⁷ CFU/cm² of Brevundimonas diminuta. This is an inherent performance claim of the filter device, independent of specific process conditions. It represents the minimum qualifying threshold for sterilization applications, yet does not guarantee effective sterilization within a specific manufacturing process. While eligible for sterilizing use, process-specific validation remains mandatory to confirm real-world sterilization performance.

Sterilizing Filter

This designation applies only to a filter verified via process-specific validation to deliver effective sterilization of feed streams under defined process parameters. A filter may only be termed a sterilizing filter upon completion of dedicated process validation.

Modern Filter Design & Performance Attributes Highlighted

The report outlines critical performance criteria for contemporary filter media and hardware
  • Compatibility with repeated steam sterilization cycles
  • Low extractables/leachables under gamma/X-ray irradiation
  • Minimal non-specific adsorption
  • High throughput and flow rates
  • Robust mechanical integrity
  • Reliable integrity test response characteristics

Single-Use Mandate & Single-Use System Guidance

Filters are specified as single-use by default. Repeated reuse requires formal validation assessing the impact of multiple sterilization cycles on filter membrane integrity.

Expanded guidance is dedicated to single-use filter assemblies and systems, underscoring core advantages: elimination of cleaning validation obligations, mitigation of cross-contamination risks, and enhanced operational safety.

Enhanced Filter Validation & Regulatory Compliance Requirements

Process-Specific Validation Aligned with Quality by Design (QbD)

Validation protocols must adopt a Quality by Design (QbD) mindset and execute bacterial retention testing under worst-case process conditions. New requirements govern redundant filtration and dual-stage filtration validation:

Redundant filtration: Integrity testing is only required for the primary filter

Dual-stage filtration: Integrity testing shall be performed on both upstream and downstream filter stages

Extractables & Leachables (E&L) Risk Management

A clear distinction is drawn between extractables and leachables. Formal risk assessment is mandated to evaluate patient safety risks associated with leachable compounds originating from filter components.

Strengthened Integrity Testing Protocols

The report reinforces the causal correlation between integrity test results (bubble point, diffusion flow) and bacterial retention performance. Test method selection is tied to filter membrane area: bubble point testing for small-area filters, diffusion flow testing for large-area filters.

New standardized protocols are introduced for product-wetted integrity testing, including mathematical proportional methodologies to convert aqueous test acceptance criteria into product-specific thresholds (e.g., bubble point ratio calculation).

Comprehensive guidance addresses PUPSIT (Post-Use Pre-Sterilization Integrity Test) implementation scenarios and associated risk mitigation. PUPSIT enables detection of filter damage incurred post-sterilization, though implementation must balance potential microbial contamination risks. A structured troubleshooting framework is provided for resolving integrity test failures.

Updated Filter Sterilization Modalities & Validation Criteria

Sterilization modalities covered include in-place steam sterilization (SIP), autoclave steam sterilization, ionizing irradiation (gamma, X-ray), and gaseous sterilization (ethylene oxide). The document articulates inherent limitations and hazards associated with repeated filter sterilization.

Mandatory validation controls are specified for each sterilization method:

Steam sterilization: Precise differential pressure control to prevent membrane mechanical damage

Irradiation sterilization: Risk assessment for polymer matrix degradation

Supplementary Guidance for Specialized Formulations

Additional validation considerations are outlined for complex biopharmaceutical products, including ATMPs, lipid nanoparticles (LNPs), and viral vector intermediates.

New Technical Appendices & Reference Materials

Additions to the technical report include:
  • Theoretical fundamentals of diffusion flow testing
  • Comparative analysis of all standard integrity test methodologies
  • Standardized troubleshooting tables for filtration process deviations

Translation Notes (Professional Pharmaceutical Regulatory Standards)

  1. Terminology strictly aligns with PDA, USP, ASTM, EMA and FDA bioprocess filtration nomenclature
  2. Regulatory jargon (QbD, PUPSIT, E&L, ATMP, SIP) retains industry-standard abbreviations with full spell-out on first occurrence
  3. Microbial, material science and filtration engineering vocabulary complies with global biomanufacturing technical writing conventions
  4. Passive formal academic tone adopted, consistent with PDA technical report official documentation style
  5. Distinction between Sterilizing-Grade Filter and Sterilizing Filter preserved per TR26 core definition logic without paraphrasing ambiguity

INQUIRY NOW

Need to Talk to an Expert?

Contact Us Via:

  • Telephone:

  • +8618651035076

  • Address:

  • No. 178, Xinghu Street, Suzhou Industrial Park, Suzhou, Jiangsu Privince, China.

Release of Revised PDA TR26: Sterilizing Filtrationof Liquids

20 Years Design and Manufacturing Experience

Contact Us

Subscribe

Sign up for the latest product and event news

Copyright @ 2026 Sino Bioengineering I Biopharma Cleanroom and Process Equipment Manufacturer     
x

Inquiry Now

Name:
Phone:
Email:
Message: